| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acceptability of using circulating microRNAs for detection of malignant germ cell tumours: initial user consultation exercise
|
Fern, L.A.
|
|
2019
|
18 |
4 |
p. 23
|
artikel
|
| 2 |
A cost comparison of open versus robotic retroperitoneal lymph node dissection for germ cell tumours
|
Singla MD, N.
|
|
2019
|
18 |
4 |
p. 24
|
artikel
|
| 3 |
Advances in the classification of germ cell tumours: Getting therapy right
|
Berney, D.M.
|
|
2019
|
18 |
4 |
p. 7
|
artikel
|
| 4 |
Alpha-fetoprotein (AFP) as a predictor of outcome for children with germ cell tumours: A report from the Malignant Germ Cell International Consortium (MaGIC)
|
O’Neill MD, A.F.
|
|
2019
|
18 |
4 |
p. 19
|
artikel
|
| 5 |
Analysing large scale TGCT data from The Cancer Genome Atlas (TCGA): Challenges and considerations
|
Smith, S.
|
|
2019
|
18 |
4 |
p. 38
|
artikel
|
| 6 |
Analysis of circulating cell-free DNA identifies several gene mutations associated with germ cell tumours
|
Hiyama, E.
|
|
2019
|
18 |
4 |
p. 22
|
artikel
|
| 7 |
An historical overview of testis cancer
|
Lorch, A.
|
|
2019
|
18 |
4 |
p. 6
|
artikel
|
| 8 |
An overview of circulating microRNAs for the management of germ cell tumours
|
Murray, M.J.
|
|
2019
|
18 |
4 |
p. 21
|
artikel
|
| 9 |
A retrospective review of weight status and dietetic intervention in children with germ cell tumours
|
Evans, R.
|
|
2019
|
18 |
4 |
p. 33
|
artikel
|
| 10 |
111-A single arm, phase 3 trial evaluating one cycle of BEP as adjuvant chemotherapy in high-risk, stage 1 non-seminomatous or combined germ cell tumours of the testis (NSGCTT)
|
Cullen, M.
|
|
2019
|
18 |
4 |
p. 8-9
|
artikel
|
| 11 |
Behaviour and outcome of paediatric immature teratomas at children cancer hospital in Egypt. What did we learn over 10 years?
|
Ahmed, S.
|
|
2019
|
18 |
4 |
p. 15
|
artikel
|
| 12 |
Building a scalable and sustainable data commons for germ cell tumour research
|
Furner, B.
|
|
2019
|
18 |
4 |
p. 7
|
artikel
|
| 13 |
Burden of late effects and challenges faced in the long-term follow-up of paediatric germ cell tumour survivors: A report from India
|
Prasad, M.
|
|
2019
|
18 |
4 |
p. 31
|
artikel
|
| 14 |
Carboplatin AUC10 monotherapy for metastatic seminoma – an updated multicentre review of outcomes in 216 patients
|
Alifrangis, C.
|
|
2019
|
18 |
4 |
p. 18
|
artikel
|
| 15 |
Causes and patterns of mortality in patients diagnosed with germ cell tumour (GCT)
|
Hamid, A.A.
|
|
2019
|
18 |
4 |
p. 29-30
|
artikel
|
| 16 |
Cisplatin resistance in germ cell tumours: Biological mechanisms and therapeutic avenues
|
Honecker, F.
|
|
2019
|
18 |
4 |
p. 29
|
artikel
|
| 17 |
Cisplatin resistance in the ovarian yolk sac tumour cell line is associated with upregulation of adult cancer stem cell (CSC) markers
|
Schmidtova, S.
|
|
2019
|
18 |
4 |
p. 31
|
artikel
|
| 18 |
Clinical characteristics, treatment, and outcomes of children with primary vaginal endodermal sinus tumours
|
Yang, J.
|
|
2019
|
18 |
4 |
p. 20
|
artikel
|
| 19 |
Clinical Outcomes of Minimally Invasive Retroperitoneal Lymph Node Dissection and Single Dose Carboplatin for Clinical Stage 2a Seminoma
|
Huddart, R.A.
|
|
2019
|
18 |
4 |
p. 24
|
artikel
|
| 20 |
Clinicopathologic predictors of outcomes in children with stage I germ cell tumours: A pooled post hoc analysis of trials from the Children’s Oncology Group
|
Singla MD, S.
|
|
2019
|
18 |
4 |
p. 17-18
|
artikel
|
| 21 |
Controlled aspiration of large paediatric ovarian cystic tumours
|
Gavens, E.
|
|
2019
|
18 |
4 |
p. 26
|
artikel
|
| 22 |
Current clinical management of relapsed testicular cancer, including the SWENOTECA experience
|
Tandstad, T.
|
|
2019
|
18 |
4 |
p. 29
|
artikel
|
| 23 |
Debate: This house believes that BEP should no longer be standard therapy for poor risk disease: Opposing view
|
Sweeney, C.J.
|
|
2019
|
18 |
4 |
p. 28-29
|
artikel
|
| 24 |
Debate: This house believes that there is no place for chemotherapy in the management of immature teratoma: Opposing view
|
de La Motte Rouge, T.
|
|
2019
|
18 |
4 |
p. 16-17
|
artikel
|
| 25 |
Debate: This house believes that there is no place for chemotherapy in the management of immature teratoma: Proposing view
|
Pashankar MD, MRCP(UK), F.
|
|
2019
|
18 |
4 |
p. 16
|
artikel
|
| 26 |
Developmental origins of testicular germ cell tumours (TGCT)
|
Rajpert-De Meyts, E.
|
|
2019
|
18 |
4 |
p. 11
|
artikel
|
| 27 |
DNA damage response mechanisms in the origins and therapeutic sensitivity of testicular germ cell tumours
|
Loehr, A.
|
|
2019
|
18 |
4 |
p. 13
|
artikel
|
| 28 |
Editorial Board
|
|
|
2019
|
18 |
4 |
p. ii-iii
|
artikel
|
| 29 |
Evaluation of inductor factors in the epithelial-mesenchymal transition (EMT) in testicular germ cell tumours (TGCT) and their roles in cisplatin resistance
|
Tufi, L.M.B.
|
|
2019
|
18 |
4 |
p. 30-31
|
artikel
|
| 30 |
False elevation of alpha-fetoprotein in malignant ovarian germ cell tumours with hepatitis B infection
|
Yang, J.
|
|
2019
|
18 |
4 |
p. 36
|
artikel
|
| 31 |
Gene expression of genes for tumour markers in testicular germ cell tumours
|
von Eyben, F.E.
|
|
2019
|
18 |
4 |
p. 41
|
artikel
|
| 32 |
Gene expression studies in platinum-resistant testicular germ cell tumours
|
Tran, B.
|
|
2019
|
18 |
4 |
p. 30
|
artikel
|
| 33 |
Generation of human primordial germ cell-like cell culture models reflecting genetic characteristics of human testicular Type II germ cell tumours for studying molecular events during early pathogenesis
|
Kobayashi, M.
|
|
2019
|
18 |
4 |
p. 12
|
artikel
|
| 34 |
Gene signatures for testicular germ cell tumours
|
von Eyben, F.E.
|
|
2019
|
18 |
4 |
p. 36
|
artikel
|
| 35 |
Genetic profiling and clonal evolution in ovarian yolk-sac tumours
|
Yang, J.
|
|
2019
|
18 |
4 |
p. 15
|
artikel
|
| 36 |
Genomic characterization of paediatric germ cell tumours
|
Pinto, M.T.
|
|
2019
|
18 |
4 |
p. 39
|
artikel
|
| 37 |
Germ cell commitment occurs after PGC colonization of the gonad in mammals
|
Nicholls, P.
|
|
2019
|
18 |
4 |
p. 11-12
|
artikel
|
| 38 |
Germline genomic architecture of testicular germ cell tumours: Lessons from a decade of experiments in genotyping and sequencing
|
Turnbull, C.
|
|
2019
|
18 |
4 |
p. 11
|
artikel
|
| 39 |
Haematological neoplasms arising in patients with primary mediastinal nonseminomatous germ cell tumour are clonally related and represent secondary somatic malignant differentiation
|
Taylor, J.
|
|
2019
|
18 |
4 |
p. 28
|
artikel
|
| 40 |
Haematopoietic stem cell transplantation for children with germ cell tumours: Experience of the National Multicentric Paediatric Germ Cell Group
|
Villela, N.C.
|
|
2019
|
18 |
4 |
p. 27-28
|
artikel
|
| 41 |
High-dose chemotherapy (HDCT) for recurrent ovarian germ cell tumours (OGCT): A single centre experience
|
Sarwar, N.
|
|
2019
|
18 |
4 |
p. 27
|
artikel
|
| 42 |
Imaging of germ cell tumours: Tips and tricks
|
Pantelidou, M.
|
|
2019
|
18 |
4 |
p. 27
|
artikel
|
| 43 |
Insights into the mechanisms of expression and (specific) secretion of microRNA (-371a-3p) in malignant paediatric and adult germ cell tumours: towards a clinical applicable protocol
|
Looijenga, L.H.J.
|
|
2019
|
18 |
4 |
p. 21
|
artikel
|
| 44 |
Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumours of childhood and adolescence
|
Xu, L.
|
|
2019
|
18 |
4 |
p. 13-14
|
artikel
|
| 45 |
Intraoperative MRI for complete resection in sacrococcygeal germ cell tumour
|
Ribeiro, R.C.
|
|
2019
|
18 |
4 |
p. 25-26
|
artikel
|
| 46 |
Introductory Letter
|
|
|
2019
|
18 |
4 |
p. iv
|
artikel
|
| 47 |
Laparoscopic surgery in paediatric ovarian tumours
|
Ribeiro, R.C.
|
|
2019
|
18 |
4 |
p. 26-27
|
artikel
|
| 48 |
Late effects and quality of survival
|
van der Pal MD PhD, H.J.
|
|
2019
|
18 |
4 |
p. 32
|
artikel
|
| 49 |
Long term follow-up of the MRC TE23 randomized phase II trial of intensive induction chemotherapy (CBOP/BEP) in poor prognosis germ cell tumours (GCT) (CRUK/05/014; ISRCTN53643604)
|
Huddart, R.A.
|
|
2019
|
18 |
4 |
p. 28
|
artikel
|
| 50 |
Malignant germ cell tumour of the head and neck in childhood: Literature review and description of a teenager case as unusual age
|
Vieira, A.G.S.
|
|
2019
|
18 |
4 |
p. 40
|
artikel
|
| 51 |
Management of Stage 1 Ovarian Tumours: Is Surveillance Enough? Pan Anglian Experience 2005–2018
|
Stoneham, S.
|
|
2019
|
18 |
4 |
p. 38
|
artikel
|
| 52 |
Mechanism and functional significance of downregulated microRNA expression in malignant germ cell tumours
|
Ferraresso, M.
|
|
2019
|
18 |
4 |
p. 22
|
artikel
|
| 53 |
Mediastinal germ cell tumours in children and adolescents: Report from the Polish Pediatric Solid Tumor Group
|
Stefanowicz, J.
|
|
2019
|
18 |
4 |
p. 39
|
artikel
|
| 54 |
Metastatic burned-out germ cell tumour of the testes and growing teratoma syndrome in a paediatric patient
|
Mahajan, P.
|
|
2019
|
18 |
4 |
p. 37
|
artikel
|
| 55 |
Mixed germ cell tumour with somatic components: Literature review and description of a case from National Multicentre Paediatric Germ Cell Group
|
Vieira, A.G.S.
|
|
2019
|
18 |
4 |
p. 40
|
artikel
|
| 56 |
Moving to a digital pathology supraregional germ cell tumour service
|
Browning, L.
|
|
2019
|
18 |
4 |
p. 8
|
artikel
|
| 57 |
Outcome of children with malignant germ cell tumours by response status at the end of induction chemotherapy
|
Fonseca, A.
|
|
2019
|
18 |
4 |
p. 19
|
artikel
|
| 58 |
Outcomes of adolescent males with extracranial metastatic germ cell tumours compared with children and young adults: A report from the Malignant Germ Cell Tumour International Consortium (MaGIC) group
|
Shaikh, F.
|
|
2019
|
18 |
4 |
p. 9
|
artikel
|
| 59 |
Outcomes of the use of carboplatin in the treatment of paediatric malignant germ cell tumours (GCTs) in the UK – Experience from GCII and GCIII trials
|
Depani, S.
|
|
2019
|
18 |
4 |
p. 19-20
|
artikel
|
| 60 |
Ovarian and testicular malignant teratomas: A comparative pathological analysis
|
Hadjiconstanti, A.A.
|
|
2019
|
18 |
4 |
p. 8
|
artikel
|
| 61 |
Ovarian germ cell tumours: More alike than different?
|
Lockley, M.
|
|
2019
|
18 |
4 |
p. 6
|
artikel
|
| 62 |
Overcoming patient factors in the care of under-served testicular cancer patients
|
Chertack MD, N.
|
|
2019
|
18 |
4 |
p. 10-11
|
artikel
|
| 63 |
Overlapping genetic aetiology in adult and paediatric germ cell tumours
|
Poynter, J.N.
|
|
2019
|
18 |
4 |
p. 7
|
artikel
|
| 64 |
Paediatric extracranial germ cell tumours in a tertiary hospital in Nigeria: Management challenges
|
Udechukwu, N.P.
|
|
2019
|
18 |
4 |
p. 39
|
artikel
|
| 65 |
Pattern of events in children, adolescents and young adults with testicular germ cell tumour (TGCT): The MAKEI-experience
|
Heimbrodt, M.
|
|
2019
|
18 |
4 |
p. 9-10
|
artikel
|
| 66 |
Pattern of events in children with sacrococcygeal germ cell tumours (GCT): The MAKEI-experience
|
Calaminus, G.
|
|
2019
|
18 |
4 |
p. 25
|
artikel
|
| 67 |
Preparing teenagers and young adults for life beyond cancer
|
Allison, L.
|
|
2019
|
18 |
4 |
p. 37
|
artikel
|
| 68 |
Primary paediatric mediastinal germ cell tumours: 11 years’ experience of children cancer hospital in Egypt
|
Arafah, O.
|
|
2019
|
18 |
4 |
p. 37
|
artikel
|
| 69 |
Principles of surgical treatment for germ cell tumours in children
|
Billmire MD, D.
|
|
2019
|
18 |
4 |
p. 25
|
artikel
|
| 70 |
Promising outcomes of extracranial germ cell tumours (eGCTs) in children & adolescents: Perspective from a developing country
|
Ramanathan, S.
|
|
2019
|
18 |
4 |
p. 38
|
artikel
|
| 71 |
Pure paediatric ovarian immature teratomas: the French experience
|
Pavone, R.
|
|
2019
|
18 |
4 |
p. 15
|
artikel
|
| 72 |
Radiogenomics and potential application to germ cell tumours
|
Sala, E.
|
|
2019
|
18 |
4 |
p. 24
|
artikel
|
| 73 |
Rare localization in 44 paediatric germ cell tumours
|
Martins, G.E.
|
|
2019
|
18 |
4 |
p. 10
|
artikel
|
| 74 |
Rational treatment reductions for good-risk metastatic seminoma patients
|
Shamash, J.
|
|
2019
|
18 |
4 |
p. 17
|
artikel
|
| 75 |
Rational trial design for stage I nonseminomatous germ cell tumour (NSGCT) patients
|
Huddart Prof., R.A.
|
|
2019
|
18 |
4 |
p. 17
|
artikel
|
| 76 |
Robot-Assisted Retroperitoneal Lymph Node Dissection
|
Thomas, B.
|
|
2019
|
18 |
4 |
p. 23-24
|
artikel
|
| 77 |
Robotic retroperitoneal lymph node dissection as primary treatment for patients with high-risk germ cell tumours
|
Bagrodia MD, A.
|
|
2019
|
18 |
4 |
p. 23
|
artikel
|
| 78 |
Role of radiotherapy for extracranial germ cell tumours: A re-visit
|
Ajithkumar, T.
|
|
2019
|
18 |
4 |
p. 31-32
|
artikel
|
| 79 |
Sacrococcygeal teratoma in children: Audit on clinical outcomes from a single centre
|
Nasher, O.
|
|
2019
|
18 |
4 |
p. 26
|
artikel
|
| 80 |
Salvage therapy for patients with recurrent and persistent malignant ovarian germ cell tumours
|
Yang, J.
|
|
2019
|
18 |
4 |
p. 36
|
artikel
|
| 81 |
Serum microRNA-371a-3p levels predict viable germ cell tumour in chemotherapy-naïve patients undergoing retroperitoneal lymph node dissection
|
Lafin PhD, J.T.
|
|
2019
|
18 |
4 |
p. 21-22
|
artikel
|
| 82 |
Site of extranodal metastasis impacts survival in patients with testicular germ cell tumours
|
Singla MD, N.
|
|
2019
|
18 |
4 |
p. 9
|
artikel
|
| 83 |
Status and recommendations for radiotherapy within interdisciplinary treatment concepts of paediatric extracranial germ cell tumours
|
Stickan-Verfürth, M.
|
|
2019
|
18 |
4 |
p. 32
|
artikel
|
| 84 |
Study of Magnetic Resonance with Diffusion in Patients in Childhood and Adolescents with Extracranial Germ Cell Tumours
|
Cavalcante, C.E.B.
|
|
2019
|
18 |
4 |
p. 25
|
artikel
|
| 85 |
Surgical management of ovarian germ cell tumours
|
Newton, C.
|
|
2019
|
18 |
4 |
p. 16
|
artikel
|
| 86 |
Survival outcomes and long-term follow-up in children treated for ovarian nonseminomatous germ cell tumours in the French TGM-95 study
|
Pavone, R.
|
|
2019
|
18 |
4 |
p. 14-15
|
artikel
|
| 87 |
Survivorship and the True North (TrueNTH) Testicular Cancer Tool
|
Tran, B.
|
|
2019
|
18 |
4 |
p. 32-33
|
artikel
|
| 88 |
Targeting oncogenic microRNAs in malignant germ cell tumours with locked nucleic acid-based inhibitors
|
Bailey, S.
|
|
2019
|
18 |
4 |
p. 22
|
artikel
|
| 89 |
Targeting the germline-specific gene regulatory network in testicular germ cell tumours
|
Tang, W.W.C.
|
|
2019
|
18 |
4 |
p. 13
|
artikel
|
| 90 |
Teratomas in Infancy and Childhood: A National Multicentric Paediatric Germ Cell Group report
|
Vieira, A.G.S.
|
|
2019
|
18 |
4 |
p. 40
|
artikel
|
| 91 |
Testicular cancer genomics England Clinical Interpretation Partnership (GECIP): A genomic exploration of testicular germ cell tumours
|
Frangou, A.M.
|
|
2019
|
18 |
4 |
p. 12-13
|
artikel
|
| 92 |
Testicular Cancer Support Groups: Is there a need?
|
Smith, S.
|
|
2019
|
18 |
4 |
p. 33
|
artikel
|
| 93 |
Testosterone Replacement in Young Male cancer Survivors (TRYMS): A six-month double-blind randomised placebo-controlled study
|
Walsh, J.S.
|
|
2019
|
18 |
4 |
p. 34
|
artikel
|
| 94 |
The avian embryo as a new patient-derived xenograft model to explore germ cell tumour aetiology, heterogeneity and therapeutic screening
|
Jarrosson, L.
|
|
2019
|
18 |
4 |
p. 14
|
artikel
|
| 95 |
The effect of lowering haematological cut-offs for treatment and blood product support on the deliverability of carboplatin AUC10 in metastatic seminoma
|
Duncan, S.
|
|
2019
|
18 |
4 |
p. 18
|
artikel
|
| 96 |
The features and management of late relapse of nonseminomatous germ cell tumours: The Royal Marsden Experience
|
Jay, A.P.M.
|
|
2019
|
18 |
4 |
p. 30
|
artikel
|
| 97 |
The impact of a supranetwork-multidisciplinary team (SMDT) on decision making in testicular cancers: A ten-year overview of the Anglian Germ Cell Cancer Collaborative Group (AGCCCG)
|
Shamash, J.
|
|
2019
|
18 |
4 |
p. 33
|
artikel
|
| 98 |
The influence of microenvironment components on cisplatin sensitivity in germ cell tumour cells
|
Skowron, M.A.
|
|
2019
|
18 |
4 |
p. 36-37
|
artikel
|
| 99 |
The Malignant Germ Cell International Consortium (MaGIC)
|
Frazier, A. Lindsay
|
|
2019
|
18 |
4 |
p. 6
|
artikel
|
| 100 |
The management of late relapse post chemotherapy in testicular cancer: Optimal outcomes with dose intense salvage chemotherapy and surgery
|
Lucas, O.
|
|
2019
|
18 |
4 |
p. 27
|
artikel
|
| 101 |
The molecular and (epi)genetic mechanisms driving microenvironment-triggered reprogramming of seminomas into an embryonal carcinoma cell fate
|
Nettersheim, D.
|
|
2019
|
18 |
4 |
p. 12
|
artikel
|
| 102 |
Treatment outcome of extracranial germ cell tumours in Chinese children in Hong Kong
|
Yau, P.W.
|
|
2019
|
18 |
4 |
p. 10
|
artikel
|
| 103 |
Validation of the MaGIC paediatric germ cell tumour risk stratification
|
Lindsay Frazier, A.
|
|
2019
|
18 |
4 |
p. 20
|
artikel
|
| 104 |
Which germinomas/dysgerminomas should be treated with chemotherapy? Is any patient high-risk?
|
Lopes, L.F.
|
|
2019
|
18 |
4 |
p. 18-19
|
artikel
|
Tijdschrift beschrijving